This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2018 Apr 1;39(13):1086-1088.

doi: 10.1093/eurheartj/ehy118.

Prolonged endogenous fibrinolysis predicts reduced survival after acute coronary syndromes

Felicita Andreotti¹, Eliano Pio Navarese², Filippo Crea¹

Affiliations

PMID: 29618031
DOI: 10.1093/eurheartj/ehy118

Comment

Prolonged endogenous fibrinolysis predicts reduced survival after acute coronary syndromes

Felicita Andreotti et al. Eur Heart J. 2018.

. 2018 Apr 1;39(13):1086-1088.

doi: 10.1093/eurheartj/ehy118.

Authors

Felicita Andreotti¹, Eliano Pio Navarese², Filippo Crea¹

Affiliations

¹ Institute of Cardiology, Catholic University Hospital, Rome, Italy.
² INOVA Heart and Vascular Institute, Falls Church, VA, USA.

PMID: 29618031
DOI: 10.1093/eurheartj/ehy118

No abstract available

PubMed Disclaimer

Comment on

Fibrin clot properties independently predict adverse clinical outcome following acute coronary syndrome: a PLATO substudy.
Sumaya W, Wallentin L, James SK, Siegbahn A, Gabrysch K, Bertilsson M, Himmelmann A, Ajjan RA, Storey RF. Sumaya W, et al. Eur Heart J. 2018 Apr 1;39(13):1078-1085. doi: 10.1093/eurheartj/ehy013. Eur Heart J. 2018. PMID: 29390064 Free PMC article. Clinical Trial.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information